Pfizer's stock is currently trading below pre-pandemic levels, despite the record-breaking year it had in 2023 for FDA approvals and the significant acquisition of Seagen. Weak sentiment is likely ...
Pfizer and Flagship Pioneering have settled on the first target for their billion-dollar, multiprogram collaboration, and it’s not exactly a surprise: The New York Big Pharma giant will work ...
, opens new tab COVID-19 antiviral treatment Paxlovid did not relieve symptoms of long COVID, according a study by Stanford University researchers. Currently, there are no proven treatments ...
, opens new tab said on Wednesday its experimental gene therapy for Duchenne muscular dystrophy (DMD) failed to improve the motion function of patients in a late-stage trial compared with a placebo.
Grocery prices stayed flat in May, after ticking down the month before. But menu prices, a source of frustration for budget-conscious consumers, are still going up — even as restaurants brag ...
FedEx wants to reduce its head count in Europe by as many as 2,000 people as the parcel-delivery giant continues its cost-cutting efforts. The Memphis-based delivery company said it would remove ...
Meta is quietly rolling out a new “Communities” feature on Messenger, the company confirmed to TechCrunch. The feature is designed to help organizations, schools and other private groups ...
FIRST ON FOX: GOP Rep. Dan Newhouse is rolling out a measure that would prevent businesses and individuals associated with the Chinese Communist Party from purchasing property adjacent to federal ...
Fox News spent much of Tuesday night suggesting that Hunter Biden’s conviction on gun-related charges is a plot—by the Department of Justice, Democrats and others—to protect President Joe ...
YouTube is rolling out thumbnail A/B testing to all channels, letting you optimize videos for higher watch time. YouTube is rolling out thumbnail A/B testing to all channels. It lets you test up ...